Article info
How to understand it
Neuropsychological testing
- Correspondence to Prof. Stefano Tamburin, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona I-37134, Italy; stefano.tamburin{at}univr.it
Citation
Neuropsychological testing
Publication history
- Accepted January 14, 2018
- First published February 22, 2018.
Online issue publication
May 18, 2018
Article Versions
- Previous version (22 February 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study
- Neuropsychological characteristics of mild cognitive impairment subgroups
- Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia
- ‘Under pressure’: is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?
- Single photon emission computed tomography perfusion differences in mild cognitive impairment
- Evidence for cortical dysfunction in clinically non-demented patients with Parkinson’s disease: a proton MR spectroscopy study
- Remote versus face-to-face neuropsychological testing for dementia research: a comparative study in people with Alzheimer’s disease, frontotemporal dementia and healthy older individuals
- Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration
- Cognitive functioning after subthalamic nucleotomy for refractory Parkinson's disease
- Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease